The efficacy and tolerability of norgestimate/ethinyl estradiol (250 μg of norgestimate/35 μg of ethinyl estradiol): Results of an open, multicenter study of 59,701 women
- 1 June 1992
- journal article
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 166 (6) , 1963-1968
- https://doi.org/10.1016/0002-9378(92)91396-r
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Pharmacologic and pharmacokinetic characteristics of norgestimate and its metabolitesAmerican Journal of Obstetrics and Gynecology, 1990
- Supportive European Data on a New Oral Contraceptive Containing NorgestimateActa Obstetricia et Gynecologica Scandinavica, 1990
- Efficacy and Clinical Profile of a New Oral Contraceptive Containing Norgestimate: U.S. Clinical TrialsActa Obstetricia et Gynecologica Scandinavica, 1990
- The Selectivity of a New ProgestinActa Obstetricia et Gynecologica Scandinavica, 1990
- ORAL CONTRACEPTIVES AND THROMBOEMBOLIC DISEASE: EFFECTS OF LOWERING ŒSTROGEN CONTENTThe Lancet, 1980
- Optimum dosage of an oral contraceptiveAmerican Journal of Obstetrics and Gynecology, 1979
- Thromboembolic Disease and the Steroidal Content of Oral Contraceptives. A Report to the Committee on Safety of DrugsBMJ, 1970
- THROMBOEMBOLISM AND ORAL CONTRACEPTIVERS: AN EPIDEMIOLOGIC CASE-CONTROL STUDY12American Journal of Epidemiology, 1969
- Investigation of deaths from pulmonary, coronary, and cerebral thrombosis and embolism in women of child-bearing age.BMJ, 1968